Could a Low-Dose eye drop stop constant watery eyes?
NCT ID NCT07676981
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This trial tests whether low-dose atropine eye drops can reduce excessive tearing (epiphora) in adults. Participants use one of two strengths (0.005% or 0.01%) in their affected eye(s) for one week. The study compares how well each dose works and monitors for any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atropine sulfate ophthalmic solution
- What this could lead to
- If it works, this could offer a simple, low-dose eye drop treatment for people bothered by constant watery eyes.
- What could go wrong
- This is a small, early-phase trial with only 18 participants and a short one-week treatment period. Results may not apply to everyone, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIPHORA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Greater Houston Eye Consultants
RECRUITINGHouston, Texas, 77098, United States
Contact Email: •••••@•••••
-
North Texas Eye Specialists
RECRUITINGMesquite, Texas, 75150, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.